References
- Abu Sin, M., Takla, A., Flieger, A., Prager, R., Fruth, A., Tietze, E., Fink, E., Korte, J., Schink, S., Höhle, M, Eckmans, T. (2012). Carrier prevalence, secondary household transmission, and long-term shedding in 2 districts during the Escherichia Coli O104:H4 outbreak in Germany, 2011. J. Infec. Dis., 207 (3), 432–438.
- Adams, N., Byrne, L., Rose, T., Adak, B., Jenkins, C., Charlett, A., Hawker, J. (2019). Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: Retrospective cohort study. BMJ Paediatr. Open, 3 (1), e000465.10.1136/bmjpo-2019-000465693698831909217
- Anonymous (2020). Seegene AllplexTM GI-Bacteria(II) Assay. http://www.seegene.com/assays/allplex_gi_bacteria_ii_assay (accessed 17.01.2020).
- Bashir, M. E., Louie, S., Shi, H. N., Nagler-Anderson, C. (2004). Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol., 172 (11), 6978–6987.10.4049/jimmunol.172.11.697815153518
- Brown, M. E., Arrieta, M.-C.,Finlay, B. B. (2013). A fresh look at the hygiene hypothesis: How intestinal microbial exposure drives immune effector responses in atopic disease. Seminars Immunol., 25 (5), 378–387.10.1016/j.smim.2013.09.00324209708
- Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., Finlay B. B. (2013). Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev., 26 (4), 822–880.10.1128/CMR.00022-13381123324092857
- Fujimura, K. E., Lynch S. V. (2015). Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe, 17 (5), 592–602.10.1016/j.chom.2015.04.007444381725974301
- Garth, J., Barnes, J. W., Krick S. (2018). Targeting cytokines as evolving treatment strategies in chronic inflammatory airway diseases. Int. J. Mol. Sci., 19 (11), 3402.10.3390/ijms19113402627501230380761
- Hu, J., Torres, A. G. (2015). Enteropathogenic Escherichia coli: Foe or innocent bystander? Clin. Microbiol. Infect., 21 (8), 729–734.10.1016/j.cmi.2015.01.015449794225726041
- Nataro, J. P., Mai, V., Johnson, J., Blackwelder, W. C., Heimer, R., Tirrell, S., Edberg, S. C., Braden, C. R., Morris, J. G., Jr., Hirshon, J. M. (2006). Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin. Infect. Dis., 43 (4), 402–407.10.1086/50586716838226
- Lima, F. M., Daurelio, F. de P., Mucci, E. R., Ahagon, C. M., dos Santos Carmo, A. M., Eterovic, A., dos Santos, L. F., Tiba-Casas, M. R., Camargo, C. H., Cergole-Novella, M. C. (2019). Epidemiology and genetic screening of diarrheagenic Escherichia coli among symptomatic and asymptomatic children. J. Med. Microbiol., 68 (7), 1033–1041.10.1099/jmm.0.00102031199225
- Manthey Carolin, F., Chloe, A. Autran, L. E., Bode, L. (2014). Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and pathogenic E. coli colonization in suckling mice. J. Pediatr. Gastroenterol. Nutr., 58 (2), 165–168.
- Mathew, S., Smatti, M. K., Al Ansari, K., Nasrallah, G. K., Thani, A. A., Yassine, H. M. (2019). Mixed viral-bacterial infections and their effects on gut microbiota and clinical illnesses in children. Scientific Reports, 9 (865).10.1038/s41598-018-37162-w635154930696865
- Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev., 11 (1), 142–201.10.1128/CMR.11.1.1421213799457432
- Ramya Raghavan, P., Subarna K. R., Ramanathan T., Suguna, A. P. (2017). Diarrheagenic Escherichia coli infections among the children of Andaman Islands with special reference to pathotype distribution and clinical profile. J. Epidemiol. Global Health, 7 (4).
- Remko Enserink, R., Scholts, R., Bruijning-Verhagen, P., Duizer, E., Vennema, H., de Boer, R., Kortbeek, T., Roelfsema, J., Smit, H., Kooistra-Smid, M., van Pelt, W. (2014). High detection rates of enteropathogens in asymptomatic children attending day care. Plos One, 9 (2).10.1371/journal.pone.0089496393354224586825
- Ruchaud-Sparagano, M. H., Maresca, M., Kenny B. (2007). Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell. Microbiol., 9 (8), 1909–1921.10.1111/j.1462-5822.2007.00923.x197480517388785
- Sabharwal, H., Cichon, C., Ölschläger, T. A., Sonnenborn, U., Schmidt M. A. (2016). Interleukin-8, CXCL1, and microRNA miR-146a responses to probiotic Escherichia coli Nissle 1917 and enteropathogenic E. coli in human intestinal epithelial T84 and monocytic THP-1 cells after apical or basolateral infection. Infect. Immun., 84 (9), 2482–2492.
- Spano, L. C., da Cunha, K. F., Monfardini, M. V., de Cassia Bergamaschi Fonseca, R., Scaletsky, I. C. A. (2017). High prevalence of diarrhea-genic Escherichia coli carrying toxin-encoding genes isolated from children and adults in southeastern Brazil ‘Results’. BMC Infect. Dis., 17, 773.10.1186/s12879-017-2872-0573557729254489
- Wesemann, D. R., Nagler, C. R. (2016). The microbiome, timing, and barrier function in the context of allergic disease. Immunity, 44 (4), 728–738.10.1016/j.immuni.2016.02.002486996427096316